Long-term results of the GnRH-agonist nafarelin acetate for the treatment of endometriosis;Langzeitergebnisse in der behandlung der endometriose mit dem GnRH-agonisten nafarelinacetat (Synarela®)

Geburtshilfe und Frauenheilkunde

Volumn 62, Issue 6, 2002, Pages 578-584

  Regidor, Pedro Antonio ^a   Heck, M ^a   Regidor, M ^a   Kimmig, R ^a   Rohr, U D ^a   Schindler, A E ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Endometriosis; Long term follow up; Nafarelinacetate (Synarela )

Indexed keywords

NAFARELIN ACETATE;

ARTICLE; CLINICAL ARTICLE; DELIVERY; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIOSIS; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; PAIN; PREGNANCY; PREGNANCY RATE; QUALITY OF LIFE; RECURRENT DISEASE; SYMPTOM;

EID: 0036301989     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32424     Document Type: Article

References (41)

1. Revised american fertility society classification of endometriosis
2. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone-releasing factor of ovine origin
3. Therapeutische perspektiven der gonadotropin-releasing-hormon-agonisten
4. Clinical aspects of endometriosis: Retrospective analysis of a personal study
5. The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhoa for monitoring therapy and for recurrence of endometriosis
6. Mapping the source and character of pain due to endometriosis by patient-assisted laparoscopy
7. Endometriosis: Role of ovarian steroids in initiation, maintenance and suppression
8. Synthesis and characterisation of a decapeptide having LH/FSH-RH activity
9. Assessing the efficacy of the American Fertility Society Classification of endometriosis: Application of a dose-response methodology
10. Localisation in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis
11. A quantitative overview of controlled trials in endometriosis associated infertility
12. Die chirurgische therapie der endometriose
13. A comparison of nafarelin acetate and danazol in the treatment of endometriosis
14. Prospektive, randomisierte studie zur wirksamkeit und verträglichkeit des GnRH-analogons Leuprorelinacetat als 1- und 3-monats-depot bei patientinnen mit uterus myomatosus
15. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain
16. Endometriosis and infertility: An integrated approach
17. Endometriosis: Current management
18. High rates of pregnancy after long-term down-regulation of women with severe endometriosis
19. Pregnancy autoimmunity in endometriosis: Relevance to infertility
20. Kombinierte endoskopische und hormonelle therapie der endometriose
21. Efficacy and safety of nafarelin in the treatment of endometriosis
22. Factors affecting postoperative pregnancy rate after endoscopic management of large endometriomata
23. Auf der spur eines rätsels: Angiogenese und endometriose
24. Behandlung der endometriose mit dem GnRH-analogon nafarelin. Wirksamkeit und verträglichkeit von synarela
25. Longterm follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur®), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome
26. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis
27. Ergebnisse eines langzeit-follow-up bei der behandlung der endometriose mit dem GnRH-agonisten leuprorelinacetat-depot (enantone®-gyn monats-depot)
28. Expression pattern of integrin adhesion molecules in endometriosis and human endometrium
29. Goserelin followed by assisted reproduction: Results in infertil women with endometriosis
30. Differentialdiagnose der endometriose
31. Expressionsmuster und zelluläre lokalisation des TGF-β1 und seiner ko-faktoren in humanem endometrium und bei der endometriose
32. Endometriose und fertilitätsstörungen
33. Was leistet die kombinierte chirurgisch-hormonelle therapie zum management der endometriose?
34. Early treatment of endometriosis with GnRH-agonists: Impact on time to recurrence
35. Individuelle endometriosebehandlung
36. Endometriose: Medikamentöse und operative behandlung
37. Endocrine dependency of endometriosis: An ultrastructural study
38. Human-gonadotropin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis
39. Laparoscopic findings in patients with pelvic pain, dysmenorrhea and sterility
40. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: Long-term follow up
41. Die medikamentöse therapie der endometriose